Lipopolysaccharide challenge: immunological effects and safety in humans

Lipopolysaccharide (LPS) is a constituent of the outer membranes of Gram-negative bacteria and an important microbial trigger that stimulates innate immunity. It is ubiquitous; it can be inoculated from the environment via inhalation of dust. The resultant inflammatory responses are essential to early host defense but may also contribute to later and/or chronic organ injury. LPS challenge either intravenously or by inhalation has been widely used for the evaluation of anti-inflammatory reagents as well as to address basic scientific questions. The acute inhalation of LPS is used as a model of acute bronchitis in human volunteers. LPS inhalation is considered a well-established method that is safe and tolerable and aids in the improved characterization of anti-inflammatory drugs in proof-of-concept studies. This article reviews immunogenicity and safety data pertaining to LPS administration, with a particular focus on LPS inhalation, which may facilitate the optimization of its use in human research.

[1]  Ragnar Rylander,et al.  Review: Endotoxin in the environment — exposure and effects , 2002 .

[2]  M. Rose,et al.  Bronchial Allergen Challenge Using the Medicaid Dosimeter , 2011, International Archives of Allergy and Immunology.

[3]  T. Sandström,et al.  Increased expression of p38 MAPK in human bronchial epithelium after lipopolysaccharide exposure , 2005, European Respiratory Journal.

[4]  S. Kalaça,et al.  Natural History and Risk Factors of Early Respiratory Responses to Exposure to Cotton Dust in Newly Exposed Workers , 2007, Journal of occupational and environmental medicine.

[5]  K Radon,et al.  Exposure assessment and lung function in pig and poultry farmers , 2001, Occupational and environmental medicine.

[6]  L. Palmberg,et al.  Influence of fluticasone and salmeterol on airway effects of inhaled organic dust;an in vivo and ex vivo study , 2000, Clinical and experimental immunology.

[7]  R. Rylander,et al.  Inflammatory response after inhalation of bacterial endotoxin assessed by the induced sputum technique , 1998, Thorax.

[8]  Y. Cormier,et al.  Assessment of particulates and bioaerosols in eastern Canadian sawmills. , 2000, AIHAJ : a journal for the science of occupational and environmental health and safety.

[9]  B. Souweine,et al.  Increase in proinflammatory cytokines in peripheral blood without haemostatic changes after LPS inhalation. , 2009, Thrombosis research.

[10]  S. Banks,et al.  Local inflammatory responses following bronchial endotoxin instillation in humans. , 2001, American journal of respiratory and critical care medicine.

[11]  D. Schwartz,et al.  Toll-like receptor 4 variants reduce airway response in human subjects at high endotoxin levels in a swine facility. , 2009, The Journal of allergy and clinical immunology.

[12]  E. Vigliani,et al.  Effects in man and rabbits of inhalation of cotton dust or extracts and purified endotoxins1 , 1969, British journal of industrial medicine.

[13]  P. Malmberg,et al.  Endotoxin levels in farming: absence of symptoms despite high exposure levels. , 1989, British journal of industrial medicine.

[14]  D. Collie,et al.  Pulmonary and systemic effects of inhaled endotoxin in control and heaves horses. , 2010, Equine veterinary journal.

[15]  C. Coe,et al.  Environmental context differentially affects behavioral, leukocyte, cortisol, and interleukin-6 responses to low doses of endotoxin in the rhesus monkey , 2007, Brain, Behavior, and Immunity.

[16]  M. Netea,et al.  Does the shape of lipid A determine the interaction of LPS with Toll-like receptors? , 2002, Trends in immunology.

[17]  H. R. Morgan,et al.  EFFECTS PRODUCED BY THE INTRAVENOUS INJECTION IN MAN OF A TOXIC ANTIGENIC MATERIAL DERIVED FROM EBERTHELLA TYPHOSA: CLINICAL, HEMATOLOGICAL, CHEMICAL AND SEROLOGICAL STUDIES. , 1942, The Journal of clinical investigation.

[18]  T. van der Poll,et al.  Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. , 2005, American journal of respiratory and critical care medicine.

[19]  M. Hernandez,et al.  Atopic asthmatic patients have reduced airway inflammatory cell recruitment after inhaled endotoxin challenge compared with healthy volunteers. , 2012, The Journal of allergy and clinical immunology.

[20]  M. Dentener,et al.  Association between CD14 polymorphisms and serum soluble CD14 levels: effect of atopy and endotoxin inhalation. , 2008, The Journal of allergy and clinical immunology.

[21]  A. Cross,et al.  Review: From therapy to experimental model: a hundred years of endotoxin administration to human subjects , 2007, Journal of endotoxin research.

[22]  S. Kharitonov,et al.  Lipopolysaccharide challenge of humans as a model for chronic obstructive lung disease exacerbations. , 2007, Contributions to microbiology.

[23]  R. Ulevitch,et al.  The effects of bacterial endotoxins on host mediation systems. A review. , 1978, The American journal of pathology.

[24]  Dave Singh,et al.  LPS challenge in healthy subjects: an investigation of neutrophil chemotaxis mechanisms involving CXCR1 and CXCR2. , 2012, International immunopharmacology.

[25]  R. Kitz,et al.  Systemic and bronchial inflammation following LPS inhalation in asthmatic and healthy subjects , 2006, Journal of endotoxin research.

[26]  R. Rylander,et al.  Airborne endotoxins and humidifier disease , 1984, Clinical allergy.

[27]  S. Vožeh.  Pharmacokinetics of inhaled drugs. , 1997, British journal of clinical pharmacology.

[28]  H. D. Hochstein,et al.  Dose-related inflammatory effects of intravenous endotoxin in humans: evaluation of a new clinical lot of Escherichia coli O:113 endotoxin. , 1999, The Journal of infectious diseases.

[29]  A. Bernard,et al.  Inhaled LPS induces blood release of Clara cell specific protein (CC16) in human beings. , 2005, The Journal of allergy and clinical immunology.

[30]  R Rylander,et al.  Byssinosis in carpet weavers exposed to wool contaminated with endotoxin. , 1987, British journal of industrial medicine.

[31]  L. Cardell,et al.  Airway inflammation evaluated in a human nasal lipopolysaccharide challenge model by investigating the effect of a CXCR2 inhibitor , 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[32]  S. Lowry,et al.  HUMAN ENDOTOXEMIA: A MODEL FOR MECHANISTIC INSIGHT AND THERAPEUTIC TARGETING , 2005, Shock.

[33]  S. Akira,et al.  Lipopolysaccharide Stimulates the MyD88-Independent Pathway and Results in Activation of IFN-Regulatory Factor 3 and the Expression of a Subset of Lipopolysaccharide-Inducible Genes1 , 2001, The Journal of Immunology.

[34]  D. Schwartz,et al.  LPS binding protein is important in the airway response to inhaled endotoxin. , 2004, The Journal of allergy and clinical immunology.

[35]  M. Rose,et al.  Methacholine challenge--comparison of an ATS protocol to a new rapid single concentration technique. , 2009, Respiratory medicine.

[36]  J L Hankinson,et al.  Inhaled endotoxin and decreased spirometric values. An exposure-response relation for cotton dust. , 1987, The New England journal of medicine.

[37]  R Rylander,et al.  Healthy subjects express differences in clinical responses to inhaled lipopolysaccharide that are related with inflammation and with atopy. , 2001, The Journal of allergy and clinical immunology.

[38]  T. van der Poll,et al.  Epinephrine Exerts Anticoagulant Effects during Human Endotoxemia , 1997, The Journal of experimental medicine.

[39]  N. Krug,et al.  Low-dose endotoxin inhalation in healthy volunteers - a challenge model for early clinical drug development , 2013, BMC Pulmonary Medicine.

[40]  R. Sergysels,et al.  Effect of inhaled endotoxin on bronchial reactivity in asthmatic and normal subjects. , 1989, Journal of applied physiology.

[41]  L. Palmberg,et al.  Fluticasone and ibuprofen do not add to the effect of salmeterol on organic dust‐induced airway inflammation and bronchial hyper‐responsiveness , 2008, Journal of internal medicine.

[42]  J. Jorgensen,et al.  Rapid detection of bacterial endotoxins in drinking water and renovated wastewater , 1976, Applied and environmental microbiology.

[43]  K. Chung,et al.  Effect of inhaled endotoxin on induced sputum in normal, atopic, and atopic asthmatic subjects , 1998, Thorax.

[44]  K. Dhaliwal,et al.  A novel subpopulation of monocyte-like cells in the human lung after lipopolysaccharide inhalation , 2012, European Respiratory Journal.

[45]  D. Schwartz,et al.  Variable airway responsiveness to inhaled lipopolysaccharide. , 1999, American journal of respiratory and critical care medicine.

[46]  I. Heimbeck,et al.  Differential Inflammatory Response to Inhaled Lipopolysaccharide Targeted Either to the Airways or the Alveoli in Man , 2012, PloS one.

[47]  D. Wegman,et al.  Longitudinal changes in pulmonary function and respiratory symptoms in cotton textile workers. A 15-yr follow-up study. , 2001, American journal of respiratory and critical care medicine.

[48]  R. Kitz,et al.  LPS inhalation challenge: a new tool to characterize the inflammatory response in humans , 2007, Medical Microbiology and Immunology.

[49]  Jerry A Nick,et al.  Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. , 2004, Blood.

[50]  Dave Singh,et al.  Inhaled LPS challenges in smokers: a study of pulmonary and systemic effects. , 2012, British journal of clinical pharmacology.

[51]  H. Fromme,et al.  Airborne Allergens, Endotoxins, and Particulate Matter in Elementary Schools, Results from Germany (LUPE 2) , 2013, Journal of occupational and environmental hygiene.

[52]  Yoshinori Nagai,et al.  MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4 , 1999, The Journal of experimental medicine.

[53]  N. Alexis,et al.  CD14-dependent airway neutrophil response to inhaled LPS: role of atopy. , 2001, The Journal of allergy and clinical immunology.

[54]  S. Akira,et al.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.

[55]  T. Walsh,et al.  A randomized controlled trial of peripheral blood mononuclear cell depletion in experimental human lung inflammation. , 2013, American journal of respiratory and critical care medicine.

[56]  Ragnar Rylander,et al.  Endotoxin in the environment--exposure and effects. , 2002, Journal of endotoxin research.

[57]  P. Thorne,et al.  Inhalation toxicology models of endotoxin- and bioaerosol-induced inflammation. , 2000, Toxicology.

[58]  R. Sergysels,et al.  Inflammatory response to acute inhalation of endotoxin in asthmatic patients. , 1992, The American review of respiratory disease.

[59]  R. Rylander,et al.  Lipopolysaccharide (LPS) inhalation in healthy subjects increases neutrophils, lymphocytes and fibronectin levels in bronchoalveolar lavage fluid. , 1992, The European respiratory journal.

[60]  P. Barnes,et al.  Inhibition of LPS-induced airway neutrophilic inflammation in healthy volunteers with an oral CXCR2 antagonist , 2013, Respiratory Research.

[61]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[62]  O. Holst,et al.  Bacterial lipopolysaccharides: relationship of structure and conformation to endotoxic activity, serological specificity and biological function. , 1990, Advances in experimental medicine and biology.

[63]  B. O'connor,et al.  Inhaled endotoxin in healthy human subjects: a dose-related study on systemic effects and peripheral CD4+ and CD8+ T cells. , 2006, Respiratory medicine.

[64]  M. Sjöstrand,et al.  Interleukin-17-producing T-helper cells and related cytokines in human airways exposed to endotoxin , 2010, European Respiratory Journal.

[65]  D. Schwartz,et al.  TLR4 mutations are associated with endotoxin hyporesponsiveness in humans , 2000, Nature Genetics.

[66]  J. Backman,et al.  Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. , 2009, American journal of respiratory and critical care medicine.

[67]  T. Brüning,et al.  Health effects due to endotoxin inhalation (review) , 2008, Archives of Toxicology.

[68]  R. Sergysels,et al.  Dose-response relationship to inhaled endotoxin in normal subjects. , 1997, American journal of respiratory and critical care medicine.

[69]  J. Gérain,et al.  Blood inflammatory response to inhaled endotoxin in normal subjects. , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[70]  J. Hasday,et al.  Bacterial endotoxin is an active component of cigarette smoke. , 1999, Chest.

[71]  Time Course of Endotoxin-Induced Airways’ Inflammation in Healthy Subjects , 2012, Inflammation.

[72]  P. Wollmer,et al.  Inhalation of LPS induces inflammatory airway responses mimicking characteristics of chronic obstructive pulmonary disease , 2012, Clinical physiology and functional imaging.